|
1
|
Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants.
|
Nat Genet
|
2007
|
12.62
|
|
2
|
Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis.
|
N Engl J Med
|
2006
|
10.95
|
|
3
|
The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment.
|
Arthritis Rheum
|
2006
|
9.37
|
|
4
|
Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial.
|
Arthritis Rheum
|
2003
|
8.50
|
|
5
|
Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus.
|
Arthritis Rheum
|
2012
|
6.85
|
|
6
|
Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis.
|
N Engl J Med
|
2005
|
6.83
|
|
7
|
Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility.
|
Nat Genet
|
2011
|
5.56
|
|
8
|
New therapies for treatment of rheumatoid arthritis.
|
Lancet
|
2007
|
4.80
|
|
9
|
Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci.
|
Nat Genet
|
2010
|
3.58
|
|
10
|
Brief report: airways abnormalities and rheumatoid arthritis-related autoantibodies in subjects without arthritis: early injury or initiating site of autoimmunity?
|
Arthritis Rheum
|
2011
|
2.74
|
|
11
|
The impact of tumor necrosis factor α inhibitors on radiographic progression in ankylosing spondylitis.
|
Arthritis Rheum
|
2013
|
2.40
|
|
12
|
Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT).
|
Arthritis Rheum
|
2005
|
2.32
|
|
13
|
Progress toward the cure of rheumatoid arthritis? The BeSt study.
|
Arthritis Rheum
|
2005
|
2.15
|
|
14
|
The concept of axial spondyloarthritis: joint statement of the spondyloarthritis research and treatment network and the Assessment of SpondyloArthritis international Society in response to the US Food and Drug Administration's comments and concerns.
|
Arthritis Rheumatol
|
2014
|
2.14
|
|
15
|
Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate. A randomized, double-blind, placebo-controlled trial.
|
Ann Intern Med
|
2002
|
1.84
|
|
16
|
Treatment of corticosteroid-responsive autoimmune inner ear disease with methotrexate: a randomized controlled trial.
|
JAMA
|
2003
|
1.81
|
|
17
|
Myocardial ischemia in the absence of obstructive coronary artery disease in systemic lupus erythematosus.
|
JACC Cardiovasc Imaging
|
2011
|
1.75
|
|
18
|
New population-based reference values for spinal mobility measures based on the 2009-2010 National Health and Nutrition Examination Survey.
|
Arthritis Rheumatol
|
2014
|
1.64
|
|
19
|
The physician Hans Reiter as prisoner of war in Nuremberg: a contextual review of his interrogations (1945-1947).
|
Semin Arthritis Rheum
|
2003
|
1.64
|
|
20
|
Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial.
|
Arthritis Rheum
|
2002
|
1.62
|
|
21
|
A prospective approach to investigating the natural history of preclinical rheumatoid arthritis (RA) using first-degree relatives of probands with RA.
|
Arthritis Rheum
|
2009
|
1.59
|
|
22
|
Porphyromonas gingivalis and disease-related autoantibodies in individuals at increased risk of rheumatoid arthritis.
|
Arthritis Rheum
|
2012
|
1.52
|
|
23
|
A multidimensional model of fatigue in patients with rheumatoid arthritis.
|
J Rheumatol
|
2012
|
1.52
|
|
24
|
Are there gender differences in severity of ankylosing spondylitis? Results from the PSOAS cohort.
|
Ann Rheum Dis
|
2006
|
1.47
|
|
25
|
Complications of the spine in ankylosing spondylitis with a focus on deformity correction.
|
Neurosurg Focus
|
2008
|
1.44
|
|
26
|
Hydroxychloroquine cardiotoxicity in systemic lupus erythematosus: a report of 2 cases and review of the literature.
|
Semin Arthritis Rheum
|
2004
|
1.35
|
|
27
|
ASsessment in Ankylosing Spondylitis International Working Group/Spondylitis Association of America recommendations for conducting clinical trials in ankylosing spondylitis.
|
Arthritis Rheum
|
2005
|
1.28
|
|
28
|
Prevalence of axial spondylarthritis in the United States: estimates from a cross-sectional survey.
|
Arthritis Care Res (Hoboken)
|
2012
|
1.28
|
|
29
|
Risk factors for functional limitations in patients with long-standing ankylosing spondylitis.
|
Arthritis Rheum
|
2005
|
1.26
|
|
30
|
The prevalence of HLA-B27 in the US: data from the US National Health and Nutrition Examination Survey, 2009.
|
Arthritis Rheum
|
2012
|
1.25
|
|
31
|
Clinical and immunogenetic prognostic factors for radiographic severity in ankylosing spondylitis.
|
Arthritis Rheum
|
2009
|
1.21
|
|
32
|
The utility of MRI in predicting radiographic erosions in the metatarsophalangeal joints of the rheumatoid foot: a prospective longitudinal cohort study.
|
Arthritis Res Ther
|
2009
|
1.08
|
|
33
|
Sputum autoantibodies in patients with established rheumatoid arthritis and subjects at risk of future clinically apparent disease.
|
Arthritis Rheum
|
2013
|
1.08
|
|
34
|
Psychological correlates of self-reported functional limitation in patients with ankylosing spondylitis.
|
Arthritis Res Ther
|
2009
|
1.08
|
|
35
|
New insights into mechanisms of therapeutic effects of antimalarial agents in SLE.
|
Nat Rev Rheumatol
|
2012
|
1.07
|
|
36
|
Brain magnetic resonance imaging in newly diagnosed systemic lupus erythematosus.
|
J Rheumatol
|
2008
|
1.07
|
|
37
|
Rilonacept for colchicine-resistant or -intolerant familial Mediterranean fever: a randomized trial.
|
Ann Intern Med
|
2012
|
1.06
|
|
38
|
Two-year efficacy and safety of infliximab treatment in patients with active psoriatic arthritis: findings of the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT).
|
J Rheumatol
|
2008
|
1.05
|
|
39
|
Whole-blood gene expression profiling in ankylosing spondylitis shows upregulation of toll-like receptor 4 and 5.
|
J Rheumatol
|
2010
|
1.05
|
|
40
|
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2012.
|
Ann Rheum Dis
|
2013
|
1.05
|
|
41
|
Multiple cytokines and chemokines are associated with rheumatoid arthritis-related autoimmunity in first-degree relatives without rheumatoid arthritis: Studies of the Aetiology of Rheumatoid Arthritis (SERA).
|
Ann Rheum Dis
|
2012
|
1.04
|
|
42
|
Genetic dissection of acute anterior uveitis reveals similarities and differences in associations observed with ankylosing spondylitis.
|
Arthritis Rheumatol
|
2015
|
1.02
|
|
43
|
A panel of biomarkers is associated with increased risk of the presence and progression of atherosclerosis in women with systemic lupus erythematosus.
|
Arthritis Rheumatol
|
2014
|
1.02
|
|
44
|
Medical signs and symptoms associated with disability, pain, and psychosocial adjustment in systemic sclerosis.
|
J Rheumatol
|
2007
|
1.00
|
|
45
|
Proceedings from the American College of Rheumatology Reproductive Health Summit: the management of fertility, pregnancy, and lactation in women with autoimmune and systemic inflammatory diseases.
|
Arthritis Care Res (Hoboken)
|
2015
|
1.00
|
|
46
|
Disease-specific patient reported outcome tools for systemic lupus erythematosus.
|
Semin Arthritis Rheum
|
2012
|
0.99
|
|
47
|
Depression and cognitive impairment in newly diagnosed systemic lupus erythematosus.
|
J Rheumatol
|
2010
|
0.99
|
|
48
|
Impact of ankylosing spondylitis on work and family life: comparisons with the US population.
|
Arthritis Rheum
|
2008
|
0.98
|
|
49
|
Performance of anti-cyclic citrullinated Peptide assays differs in subjects at increased risk of rheumatoid arthritis and subjects with established disease.
|
Arthritis Rheum
|
2013
|
0.96
|
|
50
|
Relatives without rheumatoid arthritis show reactivity to anti-citrullinated protein/peptide antibodies that are associated with arthritis-related traits: studies of the etiology of rheumatoid arthritis.
|
Arthritis Rheum
|
2013
|
0.96
|
|
51
|
The contribution of pain and depression to self-reported sleep disturbance in patients with rheumatoid arthritis.
|
Pain
|
2011
|
0.95
|
|
52
|
Sex chromosome aneuploidies among men with systemic lupus erythematosus.
|
J Autoimmun
|
2011
|
0.94
|
|
53
|
Improvement in work place and household productivity for patients with early rheumatoid arthritis treated with adalimumab plus methotrexate: work outcomes and their correlations with clinical and radiographic measures from a randomized controlled trial companion study.
|
Arthritis Care Res (Hoboken)
|
2010
|
0.94
|
|
54
|
Cognitive function in a systemic lupus erythematosus inception cohort.
|
J Rheumatol
|
2008
|
0.94
|
|
55
|
Neuroimaging evidence of white matter inflammation in newly diagnosed systemic lupus erythematosus.
|
Arthritis Rheum
|
2011
|
0.94
|
|
56
|
The epidemiology of back pain, axial spondyloarthritis and HLA-B27 in the United States.
|
Am J Med Sci
|
2013
|
0.93
|
|
57
|
Occupational physical activities and long-term functional and radiographic outcomes in patients with ankylosing spondylitis.
|
Arthritis Rheum
|
2008
|
0.93
|
|
58
|
Psychological correlates of self-reported disease activity in ankylosing spondylitis.
|
J Rheumatol
|
2010
|
0.92
|
|
59
|
Identification of polyclonal and monoclonal antibodies against tissue plasminogen activator in the antiphospholipid syndrome.
|
Arthritis Rheum
|
2005
|
0.92
|
|
60
|
The contribution of disease activity on functional limitations over time through psychological mediators: a 12-month longitudinal study in patients with ankylosing spondylitis.
|
Rheumatology (Oxford)
|
2011
|
0.91
|
|
61
|
Etanercept treatment for autoimmune inner ear disease: results of a pilot placebo-controlled study.
|
Otol Neurotol
|
2005
|
0.91
|
|
62
|
Plasma 25,OH vitamin D concentrations are not associated with rheumatoid arthritis (RA)-related autoantibodies in individuals at elevated risk for RA.
|
J Rheumatol
|
2009
|
0.91
|
|
63
|
The chromosome 16q region associated with ankylosing spondylitis includes the candidate gene tumour necrosis factor receptor type 1-associated death domain (TRADD).
|
Ann Rheum Dis
|
2009
|
0.90
|
|
64
|
An evaluation of a biopsychosocial framework for health-related quality of life and disability in rheumatoid arthritis.
|
J Psychosom Res
|
2011
|
0.90
|
|
65
|
Confirmatory factor analysis of the Pittsburgh Sleep Quality Index in rheumatoid arthritis patients.
|
Behav Sleep Med
|
2013
|
0.89
|
|
66
|
Use of pharmacogenetics, enzymatic phenotyping, and metabolite monitoring to guide treatment with azathioprine in patients with systemic lupus erythematosus.
|
J Rheumatol
|
2009
|
0.89
|
|
67
|
Safety of high-dose corticosteroids for the treatment of autoimmune inner ear disease.
|
Otol Neurotol
|
2009
|
0.88
|
|
68
|
Cost-effectiveness of sequential therapy with tumor necrosis factor antagonists in early rheumatoid arthritis.
|
J Rheumatol
|
2009
|
0.88
|
|
69
|
New insights into the role and mechanism of macrophage migration inhibitory factor in steroid-resistant patients with systemic lupus erythematosus.
|
Arthritis Res Ther
|
2012
|
0.88
|
|
70
|
Clinical validation of the watershed sign as a marker for neuropsychiatric systemic lupus erythematosus.
|
Arthritis Rheum
|
2008
|
0.88
|
|
71
|
Cervical vertebral squaring in patients without spondyloarthritis.
|
J Rheumatol
|
2012
|
0.88
|
|
72
|
Eligibility, utilization, and costs in a California Medicaid lupus population.
|
Arthritis Rheum
|
2004
|
0.87
|
|
73
|
Inflammatory bowel disease serologies in ankylosing spondylitis patients: a pilot study.
|
Arthritis Res Ther
|
2009
|
0.87
|
|
74
|
Correlates and predictors of disability in vulnerable US Hispanics with rheumatoid arthritis.
|
Arthritis Care Res (Hoboken)
|
2012
|
0.86
|
|
75
|
Cost effectiveness of different treatment strategies in the treatment of patients with moderate to severe rheumatoid arthritis in china.
|
PLoS One
|
2012
|
0.84
|
|
76
|
Biomarkers, surrogate markers, and design of clinical trials of new therapies for systemic lupus erythematosus.
|
Arthritis Rheum
|
2004
|
0.84
|
|
77
|
Markers of intestinal inflammation in patients with ankylosing spondylitis: a pilot study.
|
Arthritis Res Ther
|
2012
|
0.84
|
|
78
|
Regional radiographic damage and functional limitations in patients with ankylosing spondylitis: differences in early and late disease.
|
Arthritis Care Res (Hoboken)
|
2013
|
0.84
|
|
79
|
Idiopathic chilblains.
|
Am J Med
|
2009
|
0.83
|
|
80
|
Multiple Autoantibodies Display Association with Lymphopenia, Proteinuria, and Cellular Casts in a Large, Ethnically Diverse SLE Patient Cohort.
|
Autoimmune Dis
|
2012
|
0.83
|
|
81
|
Microvascular angina: an underappreciated cause of SLE chest pain.
|
J Rheumatol
|
2013
|
0.83
|
|
82
|
Relationship between air pollution and positivity of RA-related autoantibodies in individuals without established RA: a report on SERA.
|
Ann Rheum Dis
|
2013
|
0.83
|
|
83
|
Patient retention and hand-wrist radiograph progression of rheumatoid arthritis during a 3-year prospective study that prohibited disease modifying antirheumatic drugs.
|
J Rheumatol
|
2004
|
0.82
|
|
84
|
Lack of linkage of IL1RN genotypes with ankylosing spondylitis susceptibility.
|
Arthritis Rheum
|
2004
|
0.82
|
|
85
|
Perspectives of vulnerable U.S Hispanics with rheumatoid arthritis on depression: awareness, barriers to disclosure, and treatment options.
|
Arthritis Care Res (Hoboken)
|
2015
|
0.81
|
|
86
|
Ankylosing spondylitis: patterns of radiographic involvement--a re-examination of accepted principles in a cohort of 769 patients.
|
Radiology
|
2010
|
0.81
|
|
87
|
Validity of self-administered quality of well-being scale in musculoskeletal disease.
|
Arthritis Rheum
|
2004
|
0.81
|
|
88
|
Women with ankylosing spondylitis: a review.
|
Arthritis Rheum
|
2008
|
0.81
|
|
89
|
Ischemic stroke in a postpartum patient: understanding the epidemiology, pathogenesis, and outcome of Moyamoya disease.
|
Semin Arthritis Rheum
|
2006
|
0.81
|
|
90
|
Is there a higher genetic load of susceptibility loci in familial ankylosing spondylitis?
|
Arthritis Care Res (Hoboken)
|
2012
|
0.80
|
|
91
|
Measurement of antinuclear antibodies by multiplex immunoassay: a prospective, multicenter clinical evaluation.
|
J Rheumatol
|
2007
|
0.80
|
|
92
|
Chronic inflammatory demyelinating polyneuropathy in patients with systemic lupus erythematosus: prognosis and outcome.
|
Semin Arthritis Rheum
|
2005
|
0.79
|
|
93
|
Development and validation of the spondyloarthritis radiography module for calibration of readers using the modified Stoke Ankylosing Spondylitis Spine Score.
|
Arthritis Care Res (Hoboken)
|
2014
|
0.78
|
|
94
|
Functional limitations due to axial and peripheral joint impairments in patients with ankylosing spondylitis: are focused measures more informative?
|
Arthritis Care Res (Hoboken)
|
2013
|
0.77
|
|
95
|
Ruminating on rheumatoid arthritis and transplantation.
|
Clin Immunol
|
2005
|
0.77
|
|
96
|
A brief assessment tool for body image in systemic lupus erythematosus.
|
Body Image
|
2011
|
0.77
|
|
97
|
2006 annual research and education meeting of the Spondyloarthritis Research and Therapy Network (SPARTAN).
|
J Rheumatol
|
2007
|
0.76
|
|
98
|
The predictive power of anti-cyclic citrullinated peptide antibodies: window into understanding gene/ environment/immunity interactions.
|
J Rheumatol
|
2006
|
0.76
|
|
99
|
Summary of the 2005 annual research and education meeting of the Spondyloarthritis Research and Therapy Network (SPARTAN).
|
J Rheumatol
|
2006
|
0.76
|
|
100
|
Heritability patterns in hand osteoarthritis: the role of osteophytes.
|
Arthritis Res Ther
|
2010
|
0.75
|
|
101
|
Is rituximab a safe and effective treatment for patients with active RA, irrespective of methotrexate treatment?
|
Nat Clin Pract Rheumatol
|
2006
|
0.75
|
|
102
|
Disparities in renal replacement in lupus nephritis: current practice and future implications.
|
Arthritis Care Res (Hoboken)
|
2011
|
0.75
|
|
103
|
Expression, localization and clinical application of exogenous Smith proteins D1 in gene transfected HEp-2 cells.
|
Int J Rheum Dis
|
2012
|
0.75
|
|
104
|
Lupus registries: evolution and challenges.
|
Semin Arthritis Rheum
|
2008
|
0.75
|
|
105
|
Infection, malignancy, switching, biosimilars, antibody formation, drug survival and withdrawal, and dose reduction: what have we learned over the last year about tumor necrosis factor inhibitors in rheumatoid arthritis?
|
Curr Opin Rheumatol
|
2016
|
0.75
|
|
106
|
Subendocardial ischemia and myocarditis in systemic lupus erythematosus detected by cardiac magnetic resonance imaging.
|
J Rheumatol
|
2012
|
0.75
|
|
107
|
Systemic lupus erythematosus cardiomyopathy—a case series demonstrating a reversible form of left ventricular dysfunction.
|
Echocardiography
|
2014
|
0.75
|
|
108
|
Treating axial manifestations in ankylosing spondylitis in the presence of peripheral arthritis.
|
Nat Clin Pract Rheumatol
|
2006
|
0.75
|
|
109
|
Geode of the femur: an uncommon manifestation potentially reflecting the pathogenesis of rheumatoid arthritis.
|
J Rheumatol
|
2006
|
0.75
|
|
110
|
A longitudinal analysis of humor coping and quality of life in systemic sclerosis.
|
Psychol Health Med
|
2009
|
0.75
|